5PSQ-039 Analysis of the quality of the information registered in the electronic medical record for the correct follow-up of the treatment with vancomycin

BackgroundVancomycin is a drug with a narrow therapeutic range, in which accurate data on weight or renal function are indispensable for correct practice.PurposeTo analyse the minimum set of data necessary for a correct follow-up of patients on vancomycin treatment and to assess whether therapeutic drug monitoring (TDM) by the pharmacy service improves the quality of the data recorded in the electronic medical record (EMR).Material and methodsA retrospective clinical practice study of the case series treated with vancomycin and subsequently TDM or not during the period from 1 January 2016 to 31 December 2016.Following data was collected: TDM (yes/no), age, weight, creatinine at baseline and at the end, and Protein C Reactive (PCR) at the beginning and at the end. The data have been extracted from the EMR through the Selene®program and we used descriptive statistic using the SPSS® V23 program.ResultsOf the 264 patients treated with vancomycin, in 35% of them weight was not completed in EMR. 1.5% of the patients of the TDM group had not recorded the weight in EMR compared to 45% of patients of the non-TDM group (p